Home NDC 42043-141 cephalexin
Product NDC 42043-141
11-digit product format 420430141
Labeler code 42043
Product ID 42043-141_517b57f4-c3b9-414c-bac5-59b1008f6c34
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name cephalexin
Dosage form CAPSULE
Route ORAL
Labeler OrchidPharma Inc
Application ANDA065248
Marketing category ANDA
Marketing start 2008-01-18
Marketing end 2020-12-31
Substance CEPHALEXIN
Active strength 500 mg/1
Pharmacologic classes Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A065248-001 CEPHALEXIN CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 A065248-002 CEPHALEXIN CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A065248-001 CEPHALEXIN EQ 250MG BASE CAPSULE / ORAL AB 2005-06-28 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A065248-002 CEPHALEXIN EQ 500MG BASE CAPSULE / ORAL AB 2005-06-28 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
DailyMed Product Concepts# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CEPHALEXIN ACTIVE INGREDIENT OBN7UDS42Y CEPHALEXIN CAPSULE [ORCHIDPHARMA INC] 11 CEPHALEXIN ANHYDROUS ACTIVE MOIETY 5SFF1W6677 CEPHALEXIN CAPSULE [ORCHIDPHARMA INC] 11 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U CEPHALEXIN CAPSULE [ORCHIDPHARMA INC] 11 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 CEPHALEXIN CAPSULE [ORCHIDPHARMA INC] 11 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G CEPHALEXIN CAPSULE [ORCHIDPHARMA INC] 11 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD CEPHALEXIN CAPSULE [ORCHIDPHARMA INC] 11 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 CEPHALEXIN CAPSULE [ORCHIDPHARMA INC] 11 GELATIN INACTIVE INGREDIENT 2G86QN327L CEPHALEXIN CAPSULE [ORCHIDPHARMA INC] 11 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CEPHALEXIN CAPSULE [ORCHIDPHARMA INC] 11 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP CEPHALEXIN CAPSULE [ORCHIDPHARMA INC] 11 CEPHALEXIN ACTIVE INGREDIENT OBN7UDS42Y CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE] 1 CEPHALEXIN ACTIVE INGREDIENT OBN7UDS42Y CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] 1 CEPHALEXIN ACTIVE INGREDIENT OBN7UDS42Y CEPHALEXIN CAPSULE [MEDVANTX, INC.] 1 CEPHALEXIN ANHYDROUS ACTIVE MOIETY 5SFF1W6677 CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE] 1 CEPHALEXIN ANHYDROUS ACTIVE MOIETY 5SFF1W6677 CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] 1 CEPHALEXIN ANHYDROUS ACTIVE MOIETY 5SFF1W6677 CEPHALEXIN CAPSULE [MEDVANTX, INC.] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U CEPHALEXIN CAPSULE [MEDVANTX, INC.] 1 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] 1 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 CEPHALEXIN CAPSULE [MEDVANTX, INC.] 1 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE] 1 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] 1 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G CEPHALEXIN CAPSULE [MEDVANTX, INC.] 1 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE] 1 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD CEPHALEXIN CAPSULE [MEDVANTX, INC.] 1 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE] 1 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] 1 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 CEPHALEXIN CAPSULE [MEDVANTX, INC.] 1 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] 1 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE] 1 GELATIN INACTIVE INGREDIENT 2G86QN327L CEPHALEXIN CAPSULE [MEDVANTX, INC.] 1 GELATIN INACTIVE INGREDIENT 2G86QN327L CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE] 1 GELATIN INACTIVE INGREDIENT 2G86QN327L CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CEPHALEXIN CAPSULE [MEDVANTX, INC.] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP CEPHALEXIN CAPSULE [STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. DBA VETSOURCE] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP CEPHALEXIN CAPSULE [MEDVANTX, INC.] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP CEPHALEXIN CAPSULE [BLENHEIM PHARMACAL, INC.] 1
DailyMed RxNorm Mappings#